4//SEC Filing
BYRNES ROBERT F 4
Accession 0001479290-20-000066
CIK 0001479290other
Filed
May 14, 8:00 PM ET
Accepted
May 15, 6:35 PM ET
Size
7.9 KB
Accession
0001479290-20-000066
Insider Transaction Report
Form 4
BYRNES ROBERT F
Director
Transactions
- Award
Common Stock
2020-05-14+6,000→ 16,500 total - Award
Stock Option (Right to buy)
2020-05-14+12,000→ 12,000 totalExercise: $19.40Exp: 2030-05-13→ Common Stock (12,000 underlying)
Holdings
- 13,665(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Represents an annual restricted stock award (the "RSA") granted pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy (the "Compensation Policy"). The shares underlying the RSA shall vest on May 14, 2021, the one year anniversary from the grant date, subject to Mr. Byrnes' Continuous Service (as defined the Issuer's 2014 Equity Incentive Plan (the "Plan")) through such vesting date.
- [F2]The shares subject to the stock option shall vest on May 14, 2021, the one year anniversary from the grant date, subject to Mr. Byrnes' Continuous Service (as defined in the Plan) through such vesting date. The stock option represents an annual grant pursuant to the Compensation Policy.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001263175
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 6:35 PM ET
- Size
- 7.9 KB